The US Food and Drug Administration has approved the second CAR T-cell therapy, indicated for certain types of non-Hodgkin lymphoma. READ MORE

Research in Review

Inappropriate or unnecessary thrombophilia testing remains a frequent problem in the hospital inpatient setting, leading to significant financial ramifications and the potential for adverse medical care, according to research presented at the 2016 ASH Annual Meeting and Exposition.